Scientists from France have created a drug that reduces the risk of HIV infection by 90%. It is expected that the tool will be used as protection during sexual intercourse with spontaneous partner.
The first clinical trials of the pill was successful. The drug was tested on human volunteers at risk. According to preliminary results, the tool reduces the risk of infection of 10. The research was conducted in America.
Scientists believe that with the help of innovative medical protection can reduce the number of patients with HIV and reduce the cost of the health care system in the prevention and treatment of HIV.
HIV is a viral disease that affects the immune system. The virus itself is not a cause of severe morbidity and death. They are called associated bacterial and viral diseases, which in case of lack of immunity are usually severe and with complications.